How Does the CAR-T Cell Therapy Process Work Step by Step?
Published
A clear walkthrough of collection, manufacturing, conditioning, infusion and follow-up.
Educational Content
Health Library
Independent articles and guides on CAR-T cell therapy — process, safety, costs, quality standards, and the emerging landscape in Türkiye.
Articles are published progressively. Titles marked “Coming soon” form the planned editorial calendar to strengthen education and search visibility on key CAR-T topics.
Process & Patient Journey
What Happens Before, During and After a CAR-T Infusion?
Coming soon
Practical expectations for patients and caregivers at each stage.
Vein-to-Vein Time Explained: Why Manufacturing Speed Matters in CAR-T
Coming soon
How long the process takes and why local manufacturing can help.
Leukapheresis for CAR-T: What Patients Should Expect
Published
The cell collection procedure explained in plain language.
Lymphodepletion Before CAR-T: Why It Is Needed and How It Feels
Coming soon
The role of short-course chemotherapy before infusion.
Safety & Side Effects
Is CAR-T Cell Therapy Safe? Understanding CRS and Neurologic Side Effects
Coming soon
Balanced overview of main risks and how centers manage them.
Cytokine Release Syndrome (CRS): Symptoms, Grading and Management
Coming soon
What CRS is, how severe it can be, and standard treatments.
How Hospitals Monitor Patients After CAR-T Infusion
Coming soon
Why close observation is required in the first days and weeks.
Infection Risk After CAR-T Therapy: What Patients and Families Need to Know
Coming soon
Why infections occur and how they are prevented and treated.
Long-Term Follow-Up After CAR-T: What Doctors Watch For
Coming soon
Ongoing monitoring after the acute phase has passed.
Turkey, Quality & Local Manufacturing
These articles address common concerns about quality and safety of advanced therapies in Türkiye, emphasizing technology transfer, GMP standards and regulatory origin.
Is It Safe to Receive CAR-T Cell Therapy in Turkey?
Published
Evidence-based look at safety, infrastructure, technology transfer and quality systems.
How Technology Transfer Improves Quality in Local CAR-T Manufacturing
Published
Why transferring an already-approved process differs from starting from scratch.
From South Korea to Türkiye: What Technology Transfer Really Means for Patients
Coming soon
Practical implications of producing an approved Korean product locally.
Does Local Manufacturing Mean Lower Quality? Facts About GMP Standards
Published
Clear explanation of Good Manufacturing Practice requirements.
Why an Already-Approved Product Matters More Than a Brand-New Local Trial
Coming soon
Difference between early clinical development and a transferred approved product.
Comparing Imported CAR-T vs Locally Manufactured CAR-T in Türkiye
Coming soon
Logistics, cost, evidence base and operational differences.
Cost & Access
How Much Does CAR-T Cell Therapy Cost Around the World?
Coming soon
Approximate ranges in the US, Europe and other major markets.
Why CAR-T Treatment Can Be More Affordable in Türkiye
Published
Cost drivers and the role of local manufacturing.
What Influences the Final Cost of CAR-T Therapy for a Patient?
Coming soon
Product, hospital care, toxicity management and individual factors.
Can International Patients Access CAR-T Therapy in Turkey?
Coming soon
Practical considerations for patients traveling for evaluation.
Science & Product Understanding
What Is CD19 and Why Is It the Main Target in Many CAR-T Therapies?
Coming soon
Simple explanation of the target antigen used in B-cell malignancies.
What Makes Next-Generation CAR-T Different From Earlier Versions?
Coming soon
Costimulation, persistence and functional protection concepts.
Understanding PD-1 and TIGIT: Why Checkpoint Knockdown Matters
Coming soon
How inhibitory pathways can limit CAR-T function.
Anbal-cel Explained: Design, Clinical Data and Manufacturing Pathway
Coming soon
Overview of the product central to the technology-transfer effort in Türkiye.
Eligibility & Decision Making
Who Is a Candidate for CAR-T Cell Therapy?
Published
General criteria and why individual assessment is essential.
Questions to Ask Your Doctor Before Considering CAR-T
Coming soon
A practical checklist for patients and families.
When Is CAR-T Considered After Multiple Lines of Treatment?
Coming soon
Typical place of CAR-T in the treatment sequence.
CAR-T vs Continuing Chemotherapy or Stem Cell Transplant: Key Differences
Coming soon
High-level comparison of treatment strategies.
How to Prepare Medical Documents for a CAR-T Eligibility Review
Coming soon
What information centers usually need for a meaningful assessment.
Have a specific clinical question?
You can request a free educational second opinion by submitting key medical information.
Request Free Medical Second Opinion